USE CASE: THE ATRIA™ DATABASE
Empowering Pharmaceutical Companies & CRO’s
Quickly and easily find the right U.S. clinical investigators to help complete clinical trials on-time
Introducing
The ATRIA Database
TM
For Pharmaceutical Companies & CRO's
ATRIA is a clinical data repository containing a near census of all active trial investigators - categorized by specialty, experience, and performance - and of all U.S. clinical trials conducted since 2016. Using specialized performance-based database & analysis, ATRIA can:
ATRIA
-
Identify the most qualified potential investigators specific to the individual trial needs of Clinical Operations Teams and Clinical Study Managers
-
Provide performance scores calculated at a study level using the Leading Performance Metrics Algorithm (LPMA)
-
Use information about active U.S. clinical investigators and clinical sites through up-to-date, government-regulated data vetted by skilled professionals
Reduce cost of finding experienced investigators
Alleviate trial delays
Improve
operations
ATRIA™ Key Features:
On-demand, online database access
Designed for simplicity: easy to use, easy to explore
Pre-built reports and analysis
Create personal individual reports
Review of peers
About ATRIA™
ATRIA™ enables sponsor companies to find the most qualified US clinical investigators for clinical studies based on actual experience and performance data. The Sunshine Act requires that all payments by pharmaceutical companies to any US-based physician, as well as certain other medical professionals, be reported, classified, and verified by that physician. These payments clinical trial grants to both principal and sub-principal investigators.
We assessed these datasets to construct a near census of clinical trial activity by US-based clinical investigators since the latter half of 2014. The data is updated annually, with 2019 currently the most recent available.
With this data, it can be determined, for each clinical investigator:
-
On which clinical trials, and other related studies, the investigator has worked between 2014-2019, and;
-
For which sponsor company; and,
-
A physician’s medical specialty, address; and, vitally-
-
How the physician performed relative to others on each relevant clinical trial.
ATRIA'S LEADING PERFORMANCE METRICS ALGORITHM (LPMA)
Proprietary data algorithms determine actual relative site patient enrollment performance. A majority of the data within ATRIA comes from Open Payments (Physical Payments Sunshine Act) and ClinicalTrials.gov, enabling our approach for assessment of the site and investigator performance in the U.S. This produced two outcomes: a near census of investigator enrollment performance since 2014, and a summary of site experience and performance for all clinical trials conducted in the U.S. between 2014 - 2020.